TCL Archive In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million August 19, 1983
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Appeals Court Finds Terminally Ill Patients Have Constitutional Right To Phase I Drugs. May 5, 2006